Fuji Pharma Co., Ltd. (FRA:FUP)
Germany
· Delayed Price · Currency is EUR 9.30
-0.30 (-3.12%)
At close: Dec 5, 2025
Fuji Pharma Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2016 - 2020 |
| Market Capitalization | 229 | 217 | 194 | 179 | 177 | 220 | Upgrade
|
| Market Cap Growth | 19.22% | 12.11% | 8.06% | 1.24% | -19.45% | -30.05% | Upgrade
|
| Enterprise Value | 360 | 359 | 358 | 342 | 324 | 287 | Upgrade
|
| Last Close Price | 9.30 | 8.85 | 7.76 | 6.87 | 6.56 | 8.10 | Upgrade
|
| PE Ratio | 13.23 | 12.57 | 5.04 | 8.25 | 9.32 | 11.68 | Upgrade
|
| PS Ratio | 0.77 | 0.73 | 0.67 | 0.69 | 0.71 | 0.84 | Upgrade
|
| PB Ratio | 0.85 | 0.80 | 0.68 | 0.69 | 0.70 | 0.87 | Upgrade
|
| P/TBV Ratio | 1.20 | 1.14 | 0.94 | 0.92 | 0.99 | 0.94 | Upgrade
|
| P/FCF Ratio | 10.39 | 9.87 | 22.54 | - | - | 12.89 | Upgrade
|
| P/OCF Ratio | 6.84 | 6.50 | 7.46 | 14.78 | - | 4.74 | Upgrade
|
| EV/Sales Ratio | 1.26 | 1.21 | 1.24 | 1.32 | 1.30 | 1.09 | Upgrade
|
| EV/EBITDA Ratio | 7.26 | 6.96 | 7.56 | 7.85 | 7.04 | 6.79 | Upgrade
|
| EV/EBIT Ratio | 13.02 | 12.49 | 14.72 | 14.01 | 12.15 | 11.06 | Upgrade
|
| EV/FCF Ratio | 16.35 | 16.33 | 41.61 | - | - | 16.81 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 0.66 | 0.64 | 0.70 | 0.69 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 3.45 | 3.45 | 3.87 | 4.21 | 3.77 | 3.42 | Upgrade
|
| Debt / FCF Ratio | 8.10 | 8.10 | 21.31 | - | - | 8.47 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.53 | 0.51 | 0.51 | 0.54 | Upgrade
|
| Inventory Turnover | 1.57 | 1.57 | 1.51 | 1.39 | 1.50 | 1.70 | Upgrade
|
| Quick Ratio | 0.82 | 0.82 | 0.66 | 0.63 | 0.68 | 1.10 | Upgrade
|
| Current Ratio | 1.55 | 1.55 | 1.19 | 1.31 | 1.45 | 1.73 | Upgrade
|
| Return on Equity (ROE) | 6.49% | 6.49% | 14.17% | 8.92% | 7.87% | 6.70% | Upgrade
|
| Return on Assets (ROA) | 3.40% | 3.40% | 2.77% | 3.00% | 3.38% | 3.32% | Upgrade
|
| Return on Capital (ROIC) | 4.09% | 4.09% | 3.35% | 3.70% | 4.23% | 4.04% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.00% | 8.00% | 7.20% | 6.90% | 7.30% | 7.60% | Upgrade
|
| Earnings Yield | 7.56% | 7.96% | 19.86% | 12.12% | 10.73% | 8.56% | Upgrade
|
| FCF Yield | 9.62% | 10.13% | 4.44% | -4.98% | -22.91% | 7.76% | Upgrade
|
| Dividend Yield | 2.80% | 2.96% | 3.43% | 3.41% | 3.76% | 2.77% | Upgrade
|
| Payout Ratio | 34.53% | 34.53% | 15.82% | 26.17% | 27.04% | 33.18% | Upgrade
|
| Buyback Yield / Dilution | -0.38% | -0.38% | -0.04% | -0.03% | 9.58% | 13.77% | Upgrade
|
| Total Shareholder Return | 2.42% | 2.58% | 3.39% | 3.37% | 13.34% | 16.54% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.